| Pharmaceutical Information |
| Drug Name |
Primaquine |
| Drug ID |
BADD_D01838 |
| Description |
An aminoquinoline that is given by mouth to produce a radical cure and prevent relapse of vivax and ovale malarias following treatment with a blood schizontocide. It has also been used to prevent transmission of falciparum malaria by those returning to areas where there is a potential for re-introduction of malaria. Adverse effects include anemias and GI disturbances. (From Martindale, The Extra Pharmacopeia, 30th ed, p404) |
| Indications and Usage |
For the treatment of malaria. |
| Marketing Status |
Prescription |
| ATC Code |
P01BA03 |
| DrugBank ID |
DB01087
|
| KEGG ID |
D02126
|
| MeSH ID |
D011319
|
| PubChem ID |
4908
|
| TTD Drug ID |
D0T1LK
|
| NDC Product Code |
Not Available |
| Synonyms |
Primaquine | Primaquine Phosphate | Phosphate, Primaquine | Primacin | Primaquine Diphosphate | Diphosphate, Primaquine |
|
| Chemical Information |
| Molecular Formula |
C15H21N3O |
| CAS Registry Number |
90-34-6 |
| SMILES |
CC(CCCN)NC1=C2C(=CC(=C1)OC)C=CC=N2 |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
